Atwood BK, Straiker A and Mackie K, ‘CB2: Therapeutic Target-in-Waiting’ (2012) 38 Progress in Neuro-Psychopharmacology and Biological Psychiatry 16
Balon R, ‘Mood, Anxiety, and Physical Illness: Body and Mind, or Mind and Body?’ (2006) 23 Depression and Anxiety 377
Brisbare-Roch C, ‘Promotion of Sleep by Targeting the Orexin System in Rats, Dogs and Humans’ (2007) 13 150 <http://www.nature.com.libproxy.ucl.ac.uk/nm/journal/v13/n2/pdf/nm1544.pdf>
Carlos H. Schenck MWM, ‘Insights from Studying Human Sleep Disorders’ (2005) 437 1279 <http://www.nature.com.libproxy.ucl.ac.uk/nature/journal/v437/n7063/pdf/nature04287.pdf>
Carvalho AF and Van Bockstaele EJ, ‘Cannabinoid Modulation of Noradrenergic Circuits: Implications for Psychiatric Disorders’ (2012) 38 Progress in Neuro-Psychopharmacology and Biological Psychiatry 59
Cera N, Tartaro A and Sensi SL, ‘Modafinil Alters Intrinsic Functional Connectivity of the Right Posterior Insula: A Pharmacological Resting State fMRI Study’ (2014) 9 PLoS ONE
Cryan JF and Kaupmann K, ‘Don’t Worry “B” Happy!: A Role for GABAB Receptors in Anxiety and Depression’ (2005) 26 Trends in Pharmacological Sciences 36
Eric J. Olson KR, ‘Management of Common Sleep Disorders’ (2013) 88 231 <http://www.aafp.org/afp/2013/0815/p231.pdf>
Freund TF, ‘Interneuron Diversity Series: Rhythm and Mood in Perisomatic Inhibition’ (2003) 26 Trends in Neurosciences 489
H. Attarian OA, ‘Treatment of Disorders of Hypersomnolence’ 16 302 <http://download.springer.com/static/pdf/61/art%253A10.1007%252Fs11940-014-0302-9.pdf?auth66=1414068132_049751e80fe3aa485ba574ca1df01580&ext=.pdf>
Hill AJ and others, ‘Phytocannabinoids as Novel Therapeutic Agents in CNS Disorders’ (2012) 133 Pharmacology & Therapeutics 79
Holmes A and others, ‘Neuropeptide Systems as Novel Therapeutic Targets for Depression and Anxiety Disorders’ (2003) 24 Trends in Pharmacological Sciences 580
Hoyer D and Jacobson LH, ‘Orexin in Sleep, Addiction and More: Is the Perfect Insomnia Drug at Hand?’ (2013) 47 Neuropeptides 477
Kalueff AV and Nutt DJ, ‘Role of GABA in Anxiety and Depression’ (2007) 24 Depression and Anxiety 495
Kilduff TS and Peyron C, ‘The Hypocretin/Orexin Ligand–Receptor System: Implications for Sleep and Sleep Disorders’ (2000) 23 Trends in Neurosciences 359
Levine J and others, ‘Anxiety Disorders and Major Depression, Together or Apart’ (2001) 14 Depression and Anxiety 94
Luscher B, Shen Q and Sahir N, ‘The GABAergic Deficit Hypothesis of Major Depressive Disorder’ (2011) 16 Molecular Psychiatry 383
Mahowald MW and Schenck CH, ‘Dissociated States of Wakefulness and Sleep’ (1992) 42 Suppl. 6 Neurology 44 <http://ovidsp.uk.ovid.com/sp-3.29.1a/ovidweb.cgi?QS2=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>
Mark W. Mahowald MD, ‘Pathophysiologic Mechanisms in REM Sleep Behavior Disorder’ (2007) 7 Current Neurology and Neuroscience Reports 167 <http://link.springer.com.libproxy.ucl.ac.uk/article/10.1007/s11910-007-0013-7>
N.P. Robertson KJP, ‘Narcolepsy: Environment, Genes and Treatment’ (2014) 261 1644 <http://link.springer.com.libproxy.ucl.ac.uk/article/10.1007/s00415-014-7435-3/fulltext.html>
Saper CB and Scammell TE, ‘Emerging Therapeutics in Sleep’ (2013) 74 Annals of Neurology 435
Smith KS and Rudolph U, ‘Anxiety and Depression: Mouse Genetics and Pharmacological Approaches to the Role of GABAA Receptor Subtypes’ (2012) 62 Neuropharmacology 54
‘Sodium Oxybate: A Primer for Pharmacists in the Treatment of Narcolepsy’ <https://www.researchgate.net/profile/Kimberley_Begley2/publication/265473606_Sodium_Oxybate_A_Primer_for_Pharmacists_in_the_Treatment_of_Narcolepsy/links/54dceb110cf25b09b912dd40.pdf>
Stores G, ‘Medication for Sleep-Wake Disorders’ (2003) 88 Archives of Disease in Childhood 899
Strange PG, Brain Biochemistry and Brain Disorders (Oxford University Press 1992)
